Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
VictoryShares US 500 Volatility Wtd ETF
CFA
$550M
| $83.7M | 0.01% |
1,372,769
-96,416
| -7% | -$6.47M |
|
1002
Equinor
EQNR
$97.4B
| $83.4M | 0.01% |
2,517,863
-67,334
| -3% | -$2.43M |
|
1003
iShares Expanded Tech Sector ETF
IGM
$10.8B
| $83.2M | 0.01% |
1,806,042
-67,182
| -4% | -$3.54M |
|
1004
Criteo S.A. Ordinary Shares
CRTO
$902M
| $83.2M | 0.01% |
3,077,231
-285,953
| -9% | -$7.49M |
|
|
VSXY
1005
Victoria's Secret
VSXY
$7.95B
| $82.9M | 0.01% |
2,847,226
+1,123,321
| +65% | +$37.9M |
|
|
EMD
1006
Western Asset Emerging Markets Debt Fund
EMD
$611M
| $82.8M | 0.01% |
10,375,180
+650,482
| +7% | +$5.84M |
|
1007
Davis Select US Equity ETF
DUSA
$1.28B
| $82.7M | 0.01% |
3,278,181
+100,549
| +3% | +$2.82M |
|
1008
Goldman Sachs Future Health Care Equity ETF
GDOC
$18.7M
| $82.6M | 0.01% |
2,903,077
| – | – |
|
1009
Cboe Global Markets
CBOE
$29.8B
| $82.4M | 0.01% |
701,765
+129,905
| +23% | +$15.6M |
|
1010
Equitable Holdings
EQH
$14.4B
| $82.2M | 0.01% |
3,120,800
-223,428
| -7% | -$6.35M |
|
|
CTLT
1011
DELISTED
CATALENT, INC.
CTLT
| $82.2M | 0.01% |
1,136,417
-119,478
| -10% | -$11.9M |
|
1012
Reliance Steel & Aluminium
RS
$21.9B
| $82.2M | 0.01% |
471,182
-41,636
| -8% | -$7.65M |
|
1013
RPM International
RPM
$14.8B
| $81.8M | 0.01% |
981,315
-3,998
| -0.4% | -$355K |
|
1014
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.05B
| $81.7M | 0.01% |
4,511,649
+852,675
| +23% | +$16.5M |
|
1015
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $81.6M | 0.01% |
618,215
-5,163
| -0.8% | -$724K |
|
1016
Coherent
COHR
$63.6B
| $81.5M | 0.01% |
2,338,594
+386,599
| +20% | +$18.5M |
|
1017
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$799M
| $81.5M | 0.01% |
2,720,594
-158,581
| -6% | -$5.12M |
|
1018
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
| $81.1M | 0.01% |
948,526
-28,404
| -3% | -$2.66M |
|
|
JNPR
1019
DELISTED
Juniper Networks
JNPR
| $80.9M | 0.01% |
3,098,763
-601,734
| -16% | -$17M |
|
1020
Franklin Resources
BEN
$17B
| $80.9M | 0.01% |
3,761,074
+307,263
| +9% | +$7.9M |
|
1021
First Trust Nasdaq Oil & Gas ETF
FTXN
$162M
| $80.8M | 0.01% |
3,292,445
-127,944
| -4% | -$3.25M |
|
1022
Vanguard Industrials ETF
VIS
$8.44B
| $80.4M | 0.01% |
510,514
-20,008
| -4% | -$3.48M |
|
1023
State Street SPDR S&P Bank ETF
KBE
$1.71B
| $80.4M | 0.01% |
1,814,187
-251,444
| -12% | -$12M |
|
1024
Watsco Inc
WSO
$13.5B
| $80.2M | 0.01% |
311,327
+9,972
| +3% | +$2.7M |
|
|
IBDP
1025
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $79.9M | 0.01% |
3,282,201
+291
| +0% | +$7.18K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.